# EDGAR Filing Document

**Accession Number:** 0001257640
**File Stem:** 0001257640-23-000004
**Filing Date:** 2023-2
**Character Count:** 7841
**Document Hash:** db02cdef6d39e1784b6a1c66a0182047
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001257640-23-000004.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0001257640-23-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230222

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230222

**DATE AS OF CHANGE**: 20230222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KRONOS WORLDWIDE INC
- **CENTRAL INDEX KEY:** 0001257640
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INORGANIC CHEMICALS [2810]
- **IRS NUMBER:** 760294959
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31763
- **FILM NUMBER:** 23653425

**BUSINESS ADDRESS:**
- **STREET 1:** 5430 LBJ FREEWAY
- **STREET 2:** SUITE 1700
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75240-2620
- **BUSINESS PHONE:** 9722331700

**MAIL ADDRESS:**
- **STREET 1:** 5430 LBJ FREEWAY
- **STREET 2:** SUITE 1700
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75240-2620

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KRONOS INC
- **DATE OF NAME CHANGE:** 20030730

?xml version='1.0' encoding='UTF-8'?

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported)

**February 22, 2023**

**KRONOS WORLDWIDE, INC.**

(Exact name of registrant as specified in its charter)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Delaware** |  | **1-31763** |  | **76-0294959** |
| (State or other jurisdiction of |  | (Commission |  | (IRS Employer |
| incorporation) |  | File Number) |  | Identification No.) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**5430 LBJ Freeway, Suite 1700, Dallas, Texas** <br>(Address of principal executive offices)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**75240-2620**<br>(Zip Code) |

---

Registrant's telephone number, including area code

**(972) 233-1700**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2.):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Title of each class** |  | **Trading Symbol(s)** |  | **Name of each exchange on which registered** |
| Common Stock |  | KRO |  | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.02** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** |

---

On February 22, 2023, the registrant's board of directors elected Brian W. Christian as the registrant's executive vice president and chief operating officer. Mr. Christian was formerly the registrant's executive vice president and chief strategy officer. James M. Buch continues to serve as the registrant's president and chief executive officer.

Mr. Christian, age 44, has served as the registrant's chief operating officer since February 22, 2023 and as its executive vice president since 2016. He previously served as the registrant's chief strategy officer from 2021 to February 2023, as its vice president, strategic business development from 2011 to 2016, and as its manager of strategic and financial planning from 2009 to 2011. He currently serves as senior vice president of Contran Corporation ("Contran"), the parent corporation of the registrant's consolidated tax group. Mr. Christian has served in strategic and financial planning positions (including officer positions) with various companies related to the registrant and Contran since 2006.

Mr. Christian is an employee of Contran and provides his services to the registrant under an intercorporate services agreement between the registrant and Contran. For a description of the intercorporate services agreement, see "Certain Relationships and Transactions" in the registrant's 2022 proxy statement, which description is incorporated herein by reference. In addition, for a discussion of potential conflicts of interest of officers who serve more than one corporation, see "Certain Relationships and Transactions" in the 2022 proxy statement, which discussion is also incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 7.01** | **Regulation FD Disclosure.** |

---

The registrant hereby furnishes the information set forth in its press release issued on February 22, 2023, a copy of which is attached as Exhibit 99.1 and incorporated herein by reference. The information the registrant furnishes in this report under this Item 7.01, and the exhibit in Item 9.01, is not deemed "filed" for purposes of section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Registration statements or other documents filed with the U.S. Securities and Exchange Commission shall not incorporate this information by reference, except as otherwise expressly stated in such filing.

#### Item 9.01 Financial Statements and Exhibits.
(d)Exhibits

---

| | | |
|:---|:---|:---|
| **Item No.** |  | **Description** |
| 99.1 |  | [Press release dated February 22, 2023 issued by the registrant.](kro-20230222xex99d1.htm) |
| 104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **KRONOS WORLDWIDE, INC.** | **KRONOS WORLDWIDE, INC.** |
|  | (Registrant) | (Registrant) |
| Date: February 22, 2023 | By: | /s/ Tim C. Hafer |
|  |  | *Tim C. Hafer,* |
|  |  | *Executive Vice President and Chief Financial Officer* |

---

## Exhibit 99.1

&nbsp;&nbsp;![Graphic](kro-20230222xex99d1001.jpg)<br>

**KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDEND**

DALLAS, TEXAS – February 22, 2023 – Kronos Worldwide, Inc. (NYSE: KRO) announced that its board of directors has declared a regular quarterly dividend of nineteen cents ($0.19) per share on its common stock, payable on March 16, 2023 to stockholders of record at the close of business on March 7, 2023.

Kronos Worldwide, Inc. is a major international producer of titanium dioxide products.

\* \* \* \* \*

**Investor Relations Contact**

Bryan A. Hanley

Senior Vice President and Treasurer

Tel. 972-233-1700

------